Our strategy meeting is more than brand visibility it’s direct connection with senior clinical operations leaders, clinical trial supply chain directors and sponsor organisations actively seeking solutions.
Demonstrate trusted subject matter expertise
Secure pre-qualified executive meetings and one-to-one engagements
Contribute to strategic roundtable discussions shaping the future of clinical delivery
Expand solution influence across emerging and established life sciences hubs.
Clinical Operations executives
Clinical Trial Supply Chain & Logistics leaders
Clinical development and sponsor organisations
CRO decision makers
Strategic solution providers supporting trial execution and continuity.
Through peer-led discussions and interactive roundtables, senior leaders will explore how to optimize clinical delivery models, improve trial predictability, and strengthen end-to-end supply chain performance in an increasingly complex regulatory and operational environment. Topics are curated to reflect real world challenges faced by sponsors, biotech innovators, and CROs ensuring every conversation delivers actionable insight rather than theoretical discussion.
Emerging Biopharma / Outsourcing / Patient Recruitment
Clinical Technologies / Artificial Intelligence / Decentralized & Hybrid Trials
Early Phase, Global Site Selection & Feasibility Study
Clinical Supplies, Global Networks, Storage & Distribution
Clinical Trials In Oncology / CNS / Cell & Gene Therapies
London stands at the heart of Europe’s life sciences ecosystem making it the ideal destination for the Clinical Operations
& Clinical Trial Supply Chain Strategy Meeting 2026.
For sponsors, London not only elevates visibility but also enhances strategic influence in shaping clinical operations and trial supply chain priorities across Europe and beyond making this meeting an unmissable opportunity to connect with senior executives and decision-makers at the centre of global clinical innovation.
Europe’s Life Sciences Powerhouse: London is recognised as a leading centre for clinical research, biotech innovation and life sciences investment, attracting major pharma, emerging biotechs, CROs and advanced health tech developers from across the continent.
Global Connectivity: With world-class transport links and international accessibility, London enables easy access for delegates from Europe, North America, Middle East, and APAC expanding sponsor reach and facilitating global business development.Global Connectivity: With world-class transport links and international accessibility, London enables easy access for delegates from Europe, North America, Middle East, and APAC, expanding sponsor reach and facilitating global business development.
Proximity to Industry Leaders: The city’s concentration of multinational pharmaceutical headquarters, research institutions, regulatory bodies, and investor communities creates fertile ground for strategic collaborations and brand positioning.Proximity to Industry Leaders: The city’s concentration of multinational pharmaceutical headquarters, research institutions, regulatory bodies, and investor communities creates fertile ground for strategic collaborations and brand positioning.
Dynamic Business & Innovation Ecosystem: London’s robust financial services sector, venture capital presence, and thriving innovation clusters support life science growth and accelerate commercial partnerships.
Targeted Engagement
Thought Leadership Exposure
Brand Visibility
Roundtable Influence
Sponsorship packages are tailored and strategic, based on sponsor objectives, audience alignment, and desired level of engagement.
Are you a decision-maker in Clinical Operations and Clinical Trial Supply Chain looking to elevate your research collaborations and industry partnerships? Hear directly from sponsors who joined the Proventa International Sponsor Interest Program in London, and discover why leading biotech and pharmaceutical sponsors trust Proventa to drive strategic funding and innovation.
Book your sponsor consultation
Request the sponsorship prospectus
Align your solution with Europe’s clinical strategy leaders.
